Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of AKT phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same

Use of AKT phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same

US Patent 11852634 · Granted Dec 26, 2023

Estimated economic value: $82,565,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Diagnosis of autoimmune disease2024
Methods of treatment of HLA-B27 related inflammatory diseases and compositions r2024
Methods of treatment of HLA-B27 related inflammatory diseases and compositions r2024
Diagnosis of systemic lupus erythematosus using protein, peptide and oligonucleo2024
Peptide compounds and therapeutic uses of same2024
Diagnosis of systemic lupus erythematosus using oligonucleotides antigens2023
Diagnosis of autoimmune diseases2022
Diagnosis of systemic lupus erythematosus using protein, peptide and oligonucleo2021
Identifying antigen clusters for monitoring a global state of an immune system2021
Nanoparticle compositions for generation of regulatory T cells and treatment of 2021
Reduced keyboard disambiguating system and method thereof2020
Diagnosis of systemic lupus erythematosus using oligonucleotides antigens2020